JUNE 30, 2004
VOLUME 1 NO. 13
 

Psychs say "less pills, more Dr Phil"

Cognitive behavioural therapy is an effective alternative to meds in patients with mood disorders


"I just take each day as it comes," says Virginia Hasselbach, a housewife in her 40s. "I used to think that my meds kept my depression in check. But now I'm afraid I'm going to wake up one day and kill myself," she admits. Controversy over the safety of some psych drugs is still raging on, spreading doubt and fear among patients. But for disorders such as major depression, there's little else that you can give patients to help them cope, right? Not necessarily. Some specialists disagree with the one therapy fits all approach. A growing body of evidence now shows that talk therapy can be a potent modifier of faulty brain chemistry. This nonprescription option has even been shown to stack up to standard psychotropic drugs.

At a recent meeting of the American Association of Directors of Psychiatric Residency Training in New Orleans, Dr Ari Zaretsky, Head of the Cognitive Behaviour Therapy Clinic at Sunnybrook and Women's College Health Sciences Centre in Toronto, cited some of the many recent trials that support this new understanding of the benefits of psychotherapy. "We now have evidence-based studies showing that both cognitive behavioural therapy (CBT) and interpersonal psychotherapy produce observable biological brain effects. Of course, this shouldn't be surprising, because it's now well-known that whenever learning takes place, the brain changes," said Dr Zaretsky. He also pointed to several studies that demonstrate biological changes that accompany CBT therapy. In one, thyroid hormone levels -- known to decrease when patients respond to antidepressant drugs -- dropped in 17 depressed patients who responded favourably to 20 CBT sessions.

Seeing is believing
Brain changes in response to CBT have also been revealed via positron emission tomography (PET) scans. In one study, patients with obsessive-compulsive disorder (OCD) were randomized to two months of CBT or standard fluoxetine treatment. Subjects in both groups had PET scans at baseline and after treatment. Both sets of patients had identical brain changes -- decreases in glucose metabolism in the orbitofrontal cortex and right caudate. "The orbitofrontal cortex appears to be involved with impaired perceptions and interpretations of factors in the environment. Behavioural therapy can reduce these faulty error signals, which is reflected in the scans," explained Dr Zaretsky. In another study, 17 unmedicated patients with major depression underwent 15 to 20 sessions of CBT, and then had their brains PET scanned. These scans were then compared to ones performed on 13 other depressed patients who'd been treated successfully with paroxetine alone. Good clinical response in each treatment group was associated with brain changes. However, the changes were specific to each treatment. The CBT patients had increased metabolic activity in the hippocampus and anterior cingulate and decreased metabolism in the dorsal, ventral and medial frontal cortices. In contrast, paroxetine-treated patients had greater metabolic activity in the prefrontal cortex and decreases in the brainstem and subgenual cingulate. Dr Zaretsky finds these results particularly interesting, since the improved clinical response in each group appeared to emerge from different brain changes. "The CBT seems to work top-down, whereas pharmacotherapy works more bottom-up," said Dr Zaretsky. He believes that CBT (16 to 20 sessions) and interpersonal therapies are particularly helpful in mild to moderate depression and in all anxiety disorders -- including OCD, panic disorder, social anxiety disorder, post-traumatic stress and others. At this time, there's evidence that the improvements are sustained for at least two years post-psychotherapy. As the data comes in, more lasting effects are likely to be demonstrated.

Do long-term talk therapies induce observable brain changes too? Evidence for techniques such as psychoanalysis, which often continue for years, is harder to come by. But according to Dr Arnold M Cooper, professor of Psychiatry at Cornell University and former president of the American Psychoanalytic Association, there's research that points in that direction. Dr Cooper agrees that brain changes accompany learning, by definition. He cites research by Dr Eric Kandel, winner of the Nobel Prize in medicine last year, to demonstrate that complex chemical and structural brain changes accompany all forms of learning. "Any effective psychotherapeutic technique that results in real clinical improvement -- that is, changing counterproductive habitual responses -- is bound to be reflected by changes in the brain. We now have techniques that allow us to observe these changes."

 

 

back to top of page

 

 

 

 
 
© Parkhurst Publishing Privacy Statement
Legal Terms of Use
Site created by Spin Design T.